Be subject to the three cases of breast cancer chemotherapy

Ms. Wang is a foreign company manager, just 40 years old, she is not only career zenith, as well as with a happy and harmonious family. However, the happy life which is always a layer of waves to be set off not long ago by chance in a physical examination, so she had to face tough challenges in life of breast cancer — Ⅲ B period, looking at the certificate, on those few cold characters, Ms. Wang eager to surgery to save precious lives.

 However, doctors thought that at this time, she is not suitable for such a program, which is Why? Reporter with her problems, visited Fudan University Cancer Hospital Chemotherapy Division Professor Zhao Tiping.

 Professor Zhao told reporters that the doctor’s treatment was completely correct. Breast Cancer Phase Ⅲ B belonging to “non-local invasive cancer surgery”, must first undergo chemotherapy to shrink tumors, and then surgical excision.

 Professor Zhao considered that as the chemotherapy side effects, and may bring about serious consequences of infertility, many patients tolerated the treatment very difficult, so always want to replace in other ways, but for some breast cancer patients with chemotherapy, the significance of was still significant.

 One is directed not yet occurred distant metastasis of breast cancer patients before surgery for systemic cytotoxic therapy, neo-adjuvant chemotherapy. Professor Zhao stressed that chemotherapy for breast cancer can start the transfer of the tumor and local lymph nodes reduced; second can not be surgically removed tumor had access to surgery opportunities; again, can not do otherwise in patients with breast-conserving surgery received breast-conserving opportunities; Finally also a tumor or lymph nodes by observing the response to treatment to determine its sensitivity to chemotherapeutic drugs, and can guide the postoperative adjuvant chemotherapy.

 Second, is to reduce the risk of postoperative recurrence, adjuvant chemotherapy can be used. However, the need to note that, if met, any one of the following five conditions, you can not do chemotherapy to consider: first, the patient’s lesions less than 1 cm; second, the patient’s pathological classification of grade Ⅰ; third, axillary lymph nodes without metastasis; fourth, estrogen and progesterone receptor positive; Fifth, the age of 39 years of age. In general, the surgery needs to be done after six courses of chemotherapy. At the same time, if you want to endocrine therapy is best started before the end of chemotherapy.

 Third, is the chemotherapy of advanced breast cancer in premenopausal patients with particularly significant. For post-menopausal patients, if estrogen and progesterone receptor positive, hormonal therapy should be considered first, but if a month later, the effect is still not good, you can switch to using chemotherapy. In addition, if this part of the patient, there was no axillary lymph node metastasis, and the relatively large lesions, it should be the first choice of chemotherapy.